Paid to Promote Eye Drug, and Prescribing It Widely

Half of the 20 doctors who received the most money from Genentech to promote its drug Lucentis in 2013 were among the highest users of the drug in 2012, a federal database shows.

Source: NYT Health - December 8, 2014 Category: Consumer Health News Authors: By KATIE THOMAS and RACHEL ABRAMS Tags: Medicare Lucentis (Drug) Doctors Roche Holding AG RHHBY Other OTC Macular Degeneration Genentech Inc Avastin (Drug) Source Type: news